Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III

J Lipid Res. 1992 Jul;33(7):995-1003.

Abstract

In this study we have examined effects of synthetic polypeptide fragments of apoC-III on the kinetic properties of lipoprotein lipase (LPL) activity. Based on the loss of 79% of LPL-inhibitory activity after CNBr cleavage at the N-terminal portion of apoC-III and a systematic search for synthetic peptides with LPL-inhibitory activity spanning the apoC-III sequence, we concluded that the N-terminal domain is the most important in the modulation of LPL activity. In addition, there are multiple attachment sites in apoC-III for its interaction with LPL and these sites reside in the hydrophilic sequences of apoC-III. Probably for this reason the intact apo-CIII exhibited higher inhibitory potential than its peptide components. Based on the deduced inhibition constants derived for the synthetic apoC-III1-79 we concluded that apoC-III is likely to exhibit a physiological role in regulating LPL activity since the derived dissociation constants for the LPL-apoC-III interaction are within the physiological concentration range of plasma apoC-III. In addition, as the synthetic apoC-III1-79 lacks the carbohydrate moiety, we also concluded that the presence of the oligosaccharide in native apoC-III is not essential for its inhibitory activity on LPL. The fact that the I50 (concentration for inhibition of LPL at 50% activity) decreases for apoC-III-1 when assayed in the presence of apoC-II indicated that the activator actually caused an increased affinity between LPL and apoC-III and demonstrated that apoC-III does not compete for the activator site of apoC-II.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Apolipoprotein C-III
  • Apolipoproteins C / blood
  • Apolipoproteins C / chemical synthesis*
  • Apolipoproteins C / pharmacology
  • Catalysis
  • Cyanogen Bromide
  • Humans
  • Kinetics
  • Lipoprotein Lipase / antagonists & inhibitors*
  • Lipoproteins, VLDL / metabolism
  • Molecular Sequence Data

Substances

  • Apolipoprotein C-III
  • Apolipoproteins C
  • Lipoproteins, VLDL
  • Lipoprotein Lipase
  • Cyanogen Bromide